Related Experiment Video
Updated: Jan 3, 2026

08:31
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
11.4K
Higher Order Architecture of Designer Peptides Forms Bioinspired 10 nm siRNA Delivery System
Alicia Gamboa1, Selina F Urfano1, Katrina Hernandez1
1Department of Chemistry and Biochemistry, California State University Long Beach, 1250 Bellflower Blvd, Long Beach, California, 90840, USA.
Scientific Reports
|November 16, 2019
Summary
Scientists developed a novel peptide/siRNA nanoparticle for efficient nucleic acid delivery. This biomimetic system offers protection, rapid cellular uptake, and effective gene silencing, advancing RNA interference therapeutics.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Molecular Biology
Background:
- Biological systems, such as viruses, utilize higher-order architecture for effective nucleic acid transport.
- Previous attempts to replicate these systems using synthetic or natural polymers yielded mixed results.
- There is a need for efficient and safe delivery vehicles for nucleic acid-based therapies.
Purpose of the Study:
- To design and characterize a novel peptide/siRNA quaternary complex for siRNA delivery.
- To create a synthetic system inspired by viral capsids for enhanced nucleic acid transport.
- To evaluate the complex's efficacy in cellular uptake, siRNA release, and gene silencing.
Main Methods:
- Rational design of a peptide assembly using collagen peptide (COL) for stability and cell-penetrating peptide (CPP) for barrier penetration.
- Formation of stoichiometric, 10 nm nanoparticles through hybridization of peptide components with siRNA.
- Assessment of cellular uptake kinetics, siRNA release, gene silencing efficiency, nuclease resistance, and cytotoxicity.
Main Results:
- The peptide/siRNA quaternary complex self-assembled into 10 nm nanoparticles.
- Demonstrated rapid cellular uptake (<30 min) and effective siRNA release.
- Achieved significant gene silencing with protection against nucleases, while exhibiting no immunostimulatory or cytotoxic effects.
Conclusions:
- Synthetic quaternary structures with higher-order architecture can serve as effective delivery vehicles for nucleic acid cargo.
- The developed peptide/siRNA complex represents a promising platform for advancing RNA interference therapeutics.
- This approach offers a nuclease-resistant, non-immunostimulatory, and non-cytotoxic alternative for nucleic acid delivery.
More Related Videos
Related Concept Videos
siRNA - Small Interfering RNAs
18.2K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.2K
Nucleic Acid Structure
8.3K
The pentose sugar in DNA is deoxyribose, while in RNA the pentose sugar is ribose. The difference between the sugars is the presence of the hydroxyl group on the ribose's second carbon and a hydrogen on the deoxyribose's second carbon. The phosphate residue attaches to the hydroxyl group of the 5′ carbon of one sugar and the hydroxyl group of the 3′ carbon of the sugar of the next nucleotide, which forms a 5′ to 3′ phosphodiester linkage.
DNA Structure
DNA...
DNA Structure
DNA...
8.3K
RNA Interference
27.7K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.7K
Experimental RNAi
7.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K

